Showing results (211-220 of 1,298) with videos related to

Sort By:
Pageof 130
JAMA Cardiology|November 2, 2018
Efficacy and Safety of Drug-Eluting Stents Optimized for Biocompatibility vs Bare-Metal Stents With a Single Month of Dual Antiplatelet Therapy: A Meta-analysisRahman Shah, Sunil V Rao, Samuel B Latham, et al.
JAMA Cardiology|March 30, 2017
Primary Prevention Implantable Cardioverter Defibrillators in Patients With Nonischemic Cardiomyopathy: A Meta-analysisSana M Al-Khatib, Gregg C Fonarow, Jose A Joglar, et al.
JAMA Cardiology|March 30, 2017
Economic Analysis of Apixaban Therapy for Patients With Atrial Fibrillation From a US Perspective: Results From the ARISTOTLE Randomized Clinical TrialPatricia A Cowper, Shubin Sheng, Renato D Lopes, et al.
JAMA Cardiology|November 14, 2018
A Long-term Benefit Approach vs Standard Risk-Based Approaches for Statin Eligibility in Primary PreventionGeorge Thanassoulis, Allan D Sniderman, Michael J Pencina
JAMA Cardiology|November 15, 2018
Association of African Ancestry With Electrocardiographic Voltage and Concentric Left Ventricular Hypertrophy: The Dallas Heart StudyAya J Alame, Sonia Garg, Julia Kozlitina, et al.
JAMA Cardiology|November 13, 2018
Epigenetic Hallmarks of Fetal Early Atherosclerotic Lesions in HumansFilomena de Nigris, Francesco Cacciatore, Francesco P Mancini, et al.
JAMA Cardiology|August 1, 2019
Association of Biologic Therapy With Coronary Inflammation in Patients With Psoriasis as Assessed by Perivascular Fat Attenuation IndexYoussef A Elnabawi, Evangelos K Oikonomou, Amit K Dey, et al.
JAMA Cardiology|September 28, 2019
Time-Varying Outcomes With the Absorb Bioresorbable Vascular Scaffold During 5-Year Follow-up: A Systematic Meta-analysis and Individual Patient Data Pooled StudyGregg W Stone, Takeshi Kimura, Runlin Gao, et al.
JAMA Cardiology|February 2, 2017
Increased Cardiac Sympathetic Activity and Oxidative Stress in Habitual Electronic Cigarette Users: Implications for Cardiovascular RiskRoya S Moheimani, May Bhetraratana, Fen Yin, et al.
JAMA Cardiology|January 26, 2017
Association Between Circulating Baseline Proprotein Convertase Subtilisin Kexin Type 9 Levels and Efficacy of EvolocumabNihar R Desai, Robert P Giugliano, Scott M Wasserman, et al.
Pageof 130